Bayer: all 1,694 studies
Page 12 of 17. Open to participants first (61), then studies with results posted, then the rest; newest registration first within each.
- Non-interventional Local Study on Prescription Behavior of Anticoagulation Therapy in Secondary Stroke Prevention in Atrial Fibrillation PatientsCompletedNCT01925755
- Effect of Ketoconazole on the Pharmacokinetics of RefametinibCompletedNCT01925638Phase 1
- Study of FVIIa Variant BAY86-6150 (B0189) in Subjects With Moderate or Severe Hemophilia Types A or B With or Without InhibitorsCompletedNCT01921855Phase 1
- Refametinib in Combination With Sorafenib in RAS Mutant Hepatocellular Carcinoma (HCC)CompletedNCT01915602Phase 2
- Refametinib(BAY86-9766) in RAS Mutant Hepatocellular Carcinoma (HCC)CompletedNCT01915589Phase 2
- Phase I Dose Escalation Study With an Allosteric AKT 1/2 Inhibitor in PatientsCompletedNCT01915576Phase 1
- GLucobay M - Evaluation Of Safety and Effectiveness in Type 2 Diabetes Not Well Controlled on Monotherapy in Real Life PracticeWithdrawnNCT01915264
- Investigating the Effectiveness of Eylea in Patients With Wet Age-related Macular DegenerationCompletedNCT01914380
- Investigating Patient Characteristics of Intermediate Stage Hepatocellular Carcinoma Patients Treated With Nexavar and Their Distribution to Different Treatment Groups as Well as Determining Effectiveness and SafetyCompletedNCT01908322
- Patient and Physician Knowledge of Key Safety MessagesCompletedNCT01907048
- Study of Treatment With the Combination of Drospirenone Plus Ethinyl Estradiol Plus Levomefolate Calcium in Mexican Women Seeking ContraceptionCompletedNCT01902264Phase 3
- Non-interventional Multi-center Study on Patients Under Routine Treatment of Pulmonary Arterial Hypertension (PAH) With Inhaled Iloprost Using I-Neb as a Device for InhalationCompletedNCT01894035
- Comparative Study of BAY86-5300 With a Flexible Extended Regimen for DysmenorrheaCompletedNCT01892904Phase 3
- First-in-man Dose Escalation Study of BAY1179470 in Patients With Advanced, Refractory Solid TumorsCompletedNCT01881217Phase 1
- The Safety and Effectiveness of the Essure (Model ESS505) Device to Prevent Pregnancy in WomenCompletedNCT01861886Not applicable
- Belgian Real Life Non-interventional Study (NIS) on Xarelto in Non-valvular Atrial Fibrillation (AF) Patients Treated for the Prevention of Stroke and Systemic EmbolismCompletedNCT01855139
- Belgian Real Life Non-interventional Study (NIS) in Patients Treated With Xarelto Following an Acute Deep Vein Thrombosis (DVT)CompletedNCT01855100
- Relative Bioavailability of Oral Suspension of Rivaroxaban Compared to Standard TabletCompletedNCT01853800Phase 1
- Regorafenib in Subjects With Metastatic Colorectal Cancer (mCRC) Who Have Progressed After Standard TherapyCompletedNCT01853319Phase 3
- Regorafenib Post-marketing SurveillanceCompletedNCT01843400
- Sorafenib Concomitantly Used With TACE (Transarterial Chemoembolization) in uHCC (Unresectable Hepatocellular Carcinoma) Patients in ChinaCompletedNCT01839630
- Exploring the Efficacy of Once Daily Oral Rivaroxaban for Treatment of Thrombus in Left Atrial/Left Atrial Appendage in Subjects With Nonvalvular Atrial Fibrillation or Atrial FlutterCompletedNCT01839357Phase 3
- Descriptive, Prospective, Non-interventional Study (NIS) to Describe Mirena and Amenorrhea Related Acceptability in Contraception Indication in Medical PracticeCompletedNCT01833793
- Phase 3 Study of Dienogest for the Treatment of Endometriosis in Chinese PatientsCompletedNCT01822080Phase 3
- Safety and Efficacy of Oral BAY85-8501 in Patients With Non-CF (Cystic Fibrosis) BronchiectasisCompletedNCT01818544Phase 2
- Comparison of Efficacy, Safety and Costs of Recombinant FVIII Products Between On-demand and Secondary Prophylaxis Groups in Haemophilia A PatientsCompletedNCT01817868
- Study in Healthy Tubal Ligated Women to Evaluate Pharmacodynamics, Safety and Pharmacokinetics of BAY1002670CompletedNCT01816815Phase 1
- Radium-223 Dichloride Asian Population Study in the Treatment of CRPC Patients With Bone MetastasisCompletedNCT01810770Phase 3
- A Study to Compare the Effect of Transipeg 2.95 g or Forlax Junior 4 g in Children With ConstipationCompletedNCT01810653Phase 4
- Satisfaction/Quality of Life With Rivaroxaban in DVT (Deep Venous Thrombosis) IndicationCompletedNCT01805544
- Satisfaction/Quality of Life With Rivaroxaban in SPAF (Stroke Prevention in Atrial Fibrillation) IndicationCompletedNCT01805531
- Xarelto for Prevention of Stroke in Patients With Atrial Fibrillation in Latinamerica and EMEA RegionCompletedNCT01800006
- Dose Escalation Study of Radium-223 Dichloride in Patients With Advanced Skeletal MetastasesCompletedNCT01798108Phase 1
- Qlaira rPMS (Regulatory Post Marketing Surveillance) Study in KoreaCompletedNCT01797809
- Follow-up Study After 11 Years of Patients Who Were Included in the BENEFIT Trial (304747) With a First Demyelinating Event Suggestive of Multiple SclerosisCompletedNCT01795872Phase 4
- Regulatory Post Marketing Surveillance Study in KoreaCompletedNCT01788722
- Riociguat in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH)No longer availableNCT01784562
- Eylea Post Marketing Surveillance(PMS)CompletedNCT01783925
- Observational Description of Compliance for the Daily Ventavis Use Via the Insight Program in Class III Pulmonary Arterial Hypertension PatientsCompletedNCT01781052
- Safety and Efficacy of BAY94-9027 in Previously Treated Male Children With Haemophilia ACompletedNCT01775618Phase 3
- Evaluation of Changes in Visual Acuity in Patients With Diabetic Macular Edema (DME) Starting Treatment With an Approved Anti-VEGF TherapyCompletedNCT01771081
- Investigating the Relationship Between Sleep, Quality of Life,Other Disorders and Therapies in MS Patients on BetaferonCompletedNCT01766063
- BAY86-9766 Plus Gemcitabine Phase I Study in AsianCompletedNCT01764828Phase 1
- EYLEA [AMD-QOL(Age-Related Macular Degeneration-Quality of Life)] Post-marketing Surveillance in JapanCompletedNCT01756261
- EYLEA Age-Related Macular Degeneration (AMD) Post-marketing Surveillance in JapanCompletedNCT01756248
- Sorafenib for Residue Disease After Resection With Curative IntentCompletedNCT01751763
- Xarelto for Prevention of Stroke in Patients With Atrial Fibrillation in AsiaCompletedNCT01750788
- DIU-QoL. Quality of Life Evaluation in Intrauterine Device Users.CompletedNCT01731132
- Sorafenib in Elderly mRCCCompletedNCT01728948
- Bioequivalence Study for Acarbose / Metformin FDCCompletedNCT01728740Phase 1
- Open Label Study of BAY1082439 in Patients With Advanced CancerCompletedNCT01728311Phase 1
- First-in-man Dose Escalation Study of BAY2010112 in Patients With Prostate CancerCompletedNCT01723475Phase 1
- Assessment of Strategies for the Management of Flu-like Symptoms in MS Patients Commencing Treatment With Betaferon (INFLUENCE)CompletedNCT01706055
- Comparative Study of BAY86-5300 With an Extended Flexible Regimen for EndometriosisCompletedNCT01697111Phase 3
- Efficacy/Safety Study to Explore a New Topical Formulation in Atopic DermatitisWithdrawnNCT01691209Not applicable
- Ciprofloxacin Special Drug Use Investigation - To Investigate the Safety and Efficacy in Patients With Ciprofloxacin iv Administration Without DilutionCompletedNCT01690559
- Special Drug Use Investigation - Assessment of Efficacy and Safety in Treating Secondary Infection of Chronic Respiratory DiseaseCompletedNCT01690533
- Regorafenib in Subjects With Gastrointestinal Stromal Tumors (GIST) Who Have Progressed After Standard Therapy (Managed Access Program)No longer availableNCT01689376
- Dose Proportionality Study With BAY94-8862 IR (Immediate Release) TabletsCompletedNCT01687920Phase 1
- Special Drug Use Investigation of Glucobay ODCompletedNCT01685502
- Dose Escalation Study to Investigate Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BAY85-3934 in Subjects With Chronic Kidney Disease (CKD)CompletedNCT01679587Phase 1
- Assessment of the Safety and Efficacy of Ciproxan-I.V. in Daily Clinical Practice - Analysis Results From a Post-marketing SurveillanceCompletedNCT01670435
- Pharmacy Based Pharmacoepidemiological Observational Study With Aspirin Protect 100 mgCompletedNCT01669824
- Compare Pharmacokinetic (PK) Profiles of Naproxen Sodium, Diphenhydramine Hydrochloride, and Naproxen Sodium and Diphenhydramine Hydrochloride CombinationCompletedNCT01666678Phase 1
- Safety and Efficacy of Gadobutrol 1.0 Molar in Japanese Subjects for CNS ImagingCompletedNCT01660841Phase 3
- Comparative Pharmacokinetic Study of Two Different Strengths of BAY14-2222CompletedNCT01653639Phase 1
- Regorafenib in Subjects With Gastrointestinal Stromal Tumors (GIST) Who Have Progressed After Standard TherapyNo longer availableNCT01646593
- A Swedish Questionnaire Study to Investigate the Perception of Menstrual BleedingsCompletedNCT01643304
- Validation Study for Endometriosis PROCompletedNCT01643122
- Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual BleedingCompletedNCT01638923Phase 3
- Efficacy and Safety of a Combined Oral Contraceptive of Estradiol Valerate and Dienogest in Healthy Female SubjectsCompletedNCT01638910Phase 3
- A Phase 2/ 3 Trial to Evaluate the Efficacy and Safety of BAY86-6150CompletedNCT01625390Phase 2/3
- Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care TherapyCompletedNCT01619007
- Radium(223) Dichloride (Alpharadin) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone MetastasesCompletedNCT01618370Phase 3
- Diabetes Treatment With Glucobay in Combination With SulfonylureaCompletedNCT01613105
- Diabetes Treatment With Glucobay in Combination With MetforminCompletedNCT01612741
- Xarelto for Prevention of Stroke in Patients With Atrial FibrillationCompletedNCT01606995
- Qlaira Post-authorization Safety Study Related to Most Common Adverse Events in Mexican Women Who Wish to Avoid PregnancyCompletedNCT01602770
- Xarelto [SPAF-QOL] Post-marketing Surveillance in JapanCompletedNCT01598051
- Daily Practice Treatment and Influence of Visanne on the Patient Assessment of Quality of LifeCompletedNCT01595724
- FR01 and FR20 IUS (Intrauterine System) Wearing StudyCompletedNCT01595022Phase 1
- Survey of Prevalence of Loss of Appetite in Subject With Health DisordersCompletedNCT01592149
- Non-interventional Study of Long-term Intrauterine Contraceptives Acceptability and User SatisfactionCompletedNCT01590537
- To Evaluate Clinical Outcome and Injection Compliance of ScilinCompletedNCT01588639
- Duration of Treatment With Tyrosine Kinase Inhibitors in the Treatment of Metastatic Renal Cell CarcinomaCompletedNCT01585974
- Safety, Pharmacokinetics, Pharmacodynamics and Anti-tumor Activity of Sorafenib and Eribulin in CombinationCompletedNCT01585870Phase 1
- Asian Subjects With Metastatic Colorectal Cancer Treated With Regorafenib or Placebo After Failure of Standard TherapyCompletedNCT01584830Phase 3
- Xarelto [SPAF] Post-marketing Surveillance in JapanCompletedNCT01582737
- Clinical Study to Evaluate the Maximum Tolerated Dose of BAY1000394 When Given Together With Chemotherapy and the Effectiveness of This Combination Treatment in Shrinking a Specific Type of Lung Tumors (Small Cell Lung Cancer)TerminatedNCT01573338Phase 1/2
- Safety, Biodistribution, Radiation Dosimetry and Pharmacokinetics Study of BAY88-8223 in Japanese PatientsCompletedNCT01565746Phase 1
- A Phase III Study to Evaluate the Safety, Efficacy and Pharmacokinetics/Pharmacodynamics of BAYQ3939 in Patients With Bacterial PneumoniaCompletedNCT01561794Phase 3
- Nexavar Dosing in Renal Cancer Patients in "Real-life" SettingCompletedNCT01557127
- A 3-fold Crossover Bioequivalence Study Between Glucobay ODT (Orally Disintegrating Tablet) 100 mg and Glucobay Standard Tablet 100 mgCompletedNCT01554631Phase 1
- Efficacy of a Single Dose of Aspirin vs. Acetaminophen in Tension Type HeadacheTerminatedNCT01552798Phase 3
- Sorafenib in Hepatocellular Carcinoma Clinical Practice in ItalyCompletedNCT01539681
- Regorafenib in Subjects With Metastatic Colorectal Cancer (CRC) Who Have Progressed After Standard TherapyNo longer availableNCT01538680
- Study to Characterize Lung Deposition, Pharmacokinetics, Safety and Tolerability of Single Inhalations of Radiolabeled Ciprofloxacin Dry Powder in Healthy Subjects and Patients With Chronic Lung DiseasesCompletedNCT01538667Phase 1
- Study to Observe Safety of Xarelto in VTE Prophlylaxis After Elective TKR (Total Knee Replacement) or THR (Total Hip Replacement)WithdrawnNCT01523418
- Controlled Release Nifedipine and Valsartan Combination Therapy in Patients With Essential HypertensionCompletedNCT01518855Phase 4
- Open Study of BAY77-1931 (Lanthanum Carbonate) in Continuous Ambulatory Peritoneal Dialysis PatientsCompletedNCT01518387Phase 3